Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.900 | None | 0.982 | 109 | 15 | 1990 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.700 | None | 0.989 | 89 | 68 | 1991 | 2018 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.700 | None | 0.985 | 65 | 7 | 1997 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
group | 0.700 | None | 1.000 | 17 | 1 | 1996 | 2016 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
group | 0.600 | None | 1.000 | 37 | 0 | 1998 | 2015 | ||||||||
|
dihydropyrimidine dehydrogenase | 0.493 | 0.846 | 3.4E-22 |
|
group | 0.600 | None | 0.952 | 21 | 0 | 1999 | 2016 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.500 | None | 0.983 | 117 | 12 | 1990 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.500 | None | 0.978 | 93 | 11 | 2002 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.500 | None | 0.976 | 42 | 2 | 2003 | 2019 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
group | 0.500 | None | 1.000 | 21 | 8 | 1996 | 2016 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
group | 0.500 | None | 0.950 | 20 | 2 | 1999 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.490 | None | 1.000 | 24 | 32 | 2004 | 2019 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
group | 0.490 | None | 1.000 | 15 | 2 | 2002 | 2019 | ||||||||
|
gremlin 1, DAN family BMP antagonist | 0.508 | 0.808 | 0.47 |
|
group | 0.430 | None | 1.000 | 9 | 3 | 2008 | 2020 | ||||||||
|
cyclin D2 | 0.477 | 0.808 | 0.99 |
|
group | 0.420 | None | 1.000 | 5 | 3 | 2011 | 2019 | ||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
group | 0.410 | None | 1.000 | 17 | 7 | 2007 | 2019 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
group | 0.410 | None | 1.000 | 10 | 6 | 2006 | 2016 | ||||||||
|
bone morphogenetic protein 4 | 0.422 | 0.808 | 0.96 |
|
group | 0.410 | None | 1.000 | 4 | 1 | 2008 | 2019 | ||||||||
|
Kruppel like factor 5 | 0.534 | 0.769 | 0.82 |
|
group | 0.410 | None | 1.000 | 3 | 1 | 2008 | 2019 | ||||||||
|
BOC cell adhesion associated, oncogene regulated | 0.666 | 0.423 | 1.7E-07 |
|
group | 0.410 | None | 1.000 | 2 | 1 | 2018 | 2019 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
group | 0.400 | None | 1.000 | 61 | 0 | 1997 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 1.000 | 43 | 0 | 1999 | 2019 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
group | 0.400 | None | 1.000 | 31 | 0 | 1996 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.400 | None | 1.000 | 22 | 1 | 2002 | 2014 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
group | 0.400 | None | 1.000 | 13 | 0 | 1990 | 2017 |